glp-1 obesity drug news today oct 2025 Lilly launches pill, kicking off showdown with Novo Nordisk Outlook for Obesity in 2026:

Strong clinical outcomes and government approval of semaglutide for weight management are supporting market expansion

To view digital features for this article, go to Introduction For several decades, N -acetylcysteine (NAC) has been used in clinical practice worldwide in a variety of indications: as a mucolytic, in acetaminophen intoxication, doxorubicin-induced cardiotoxicity and in other cardiovascular, respiratory and psychiatric disorders [1]

Allulose may be gut-friendly, by analogy to other low-digestible sweeteners that also reach the colon intact and are fermented by bacteria to produce SCFAs

Avoiding Triggers Avoiding Triggers Recognizing and avoiding triggers can lower the probability or severity of future CVS episodes